https://www.selleckchem.com/pr....oducts/BIX-02189.htm
The greatest reductions in complication rates were seen for new-onset back pain (88.13%; p = 0.001) and wound complications (95.05%; p less then 0.001) at 30 days, new-onset motor deficits (90.11%; p = 0.004) and wound complications (85.16%; p less then 0.001) at 90 days, and new-onset motor deficits (85.16%; p = 0.002), wound (85.16%; p less then 0.001), and medical complications (75.72%; p less then 0.001) at 1 year. RG was associated with a 92.58% (p = 0.002) reduction in revision rate at 90 days and a 66.08% (p = 0.026) re
Like
Comment
Share
